Category: Stock Market

Clinuvel Pharmaceuticals Limited (ASX: CUV) shares are having a strong finish to the week.

In morning trade, the ASX 300 healthcare stock is up a sizeable 12% to $17.00.

Why is this ASX 300 healthcare stock rocketing?

Investors have been buying Clinuvel’s shares this morning after it announced the final set of results from its CUV151 study. It is evaluating the DNA-repair capacity of afamelanotide on skin of healthy volunteers exposed to ultraviolet (UV) radiation.

This study was undertaken at Salford Royal Hospital in Manchester. It is a centre globally acknowledged for its expertise in assessing the effects of UV-induced skin damage.

The results from CUV151 were presented overnight at the British Association of Dermatologists meeting in Manchester.

According to the release, the analysis of biopsies from seven patients with fair skin types taken prior to, and six days after afamelanotide treatment, illustrated that without afamelanotide, UV-irradiation resulted in 625 differentially expressed genes (DEGs) in comparison to non-irradiated skin.

However, with afamelanotide, the DEGs between irradiated versus non-irradiated skin reduced to 183. This is a factor 3.4 less DEGs (p<0.05).

Management notes that the genes evaluated are found to be crucial in the regulation of DNA repair and inflammatory reactions following solar and UV exposure.

What does this mean for CUV151?

The release highlights that for the overall XP-DNA Repair Program, the RNA sequencing results indicate that critical genes expressed after UV-damage can be positively affected with afamelanotide treatment.

For the general population, and specifically individuals with a fair skin type who easily burn in the sun, the results indicate that afamelanotide can reduce oxidative damage and inflammatory reactions after sun exposure and skin damage.

The ASX 300 healthcare stock’s chief scientific officer, Dr Dennis Wright, was pleased with the results. He said:

The results from RNA sequencing complement the earlier results we saw from immunohistochemistry, in that afamelanotide consistently seems to assist repair of UV-damaged DNA in the skin.

Dr Wright revealed that the company plans to confirm these results in a final study. He said:

The significance of these results evaluating the use of afamelanotide in reducing oxidative and inflammatory damage caused by UV is high for those at high risk of solar damage, sunburn and skin cancers, hence we will repeat and confirm these results in a final study.

Despite today’s strong gain, the Clinuvel share price remains down approximately 6% since this time last year.

The post Why is this ASX 300 healthcare stock surging 12% today? appeared first on The Motley Fool Australia.

More reading

• Guess which ASX 300 share could rise over 50%
• 5 things to watch on the ASX 200 on Tuesday

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Bank of Queensland Ltd (ASX: BOQ) share price underperformed the S&P/ASX 200 Index (ASX: XJO) during the last year. In the 12 months to 30 June 2024, the BOQ share price rose 5.8% while the ASX 200 went up 7.8%.

BOQ has a different financial year from the regular Australian tax year. The Bank of Queensland’s financial year runs to 31 August each year, so there are still a couple of months left to run.

We recently heard from the bank about how it performed in the six months to February 2024, which saw a number of financial measures go the wrong way. The market also heard several interesting comments about the bank’s outlook.

Earnings recap

BOQ reported that its HY24 cash earnings after tax fell 33% to $172 million. The ASX bank share reported its housing loan portfolio saw a 1% decline in the second half of FY23 or $411 million in dollar terms. It said a continued focus on economic return resulted in a contraction of the housing portfolio.

The company said its net interest margin (NIM) dropped by 3 basis points (0.03%) – compared to the second half of FY23 – to 1.55%. That means it’s making a smaller amount of profit on each dollar it lends.

BOQ blamed “competitive pressures” for its lower margins and the weak lending growth performance. Cash operating expenses also grew by 6% year over year to $524 million.

BOQ also reported that its cash return on equity (ROE) dropped to 5.8%, down from 8.4% in the first half of FY23.

Thankfully, asset quality remains “sound”, despite the higher interest rate environment.

The managing director and CEO Patrick Allaway said at the time of the result announcement:

This result has been impacted by continuing industry headwinds, with heightened competition for lending and deposits and higher funding costs. Pleasingly, in a reduced revenue and high inflation environment, we have held BAU [business as usual] cost growth at just 1.2% in the half.

Outlook for BOQ shares

When the bank announced its HY24 first-half result, it also provided some outlook commentary that could apply to the rest of FY24 and FY25.

BOQ said its loan impairment expense is expected to remain below long run averages, which sounds positive. The bank said it remains “optimistic on the long-term view”.

However, the regional bank said it expects revenue and margin pressures “to moderate” in the second half of 2024, though deposit competition “to continue.” It’s also expecting the home lending decline “to moderate”, and that business banking growth can increase.

The bank’s costs are expected to keep increasing due to inflation and continued investment in the business. BOQ said it’s on track to deliver single-digit business as usual (BAU) expense growth in the second half of FY24.

In terms of analyst expectations, the broker UBS is expecting BOQ’s cash earnings to drop from $450 million in FY23 to $294 million in FY24. However, the ASX bank share could then see cash profit recover to $320 million, though it would still be lower than FY23.

In fact, while UBS has pencilled in a steady recovery of profit in the coming financial years, FY28 is still only expected to show a cash profit of $406 million – lower than FY23.

The broker suggested a higher return on equity (ROE) and BOQ share price re-rating are dependent on improving the NIM and costs.

According to UBS, the BOQ share price is valued at 14x FY25’s estimated earnings.

The post Can things get better for BOQ shares in FY25? appeared first on The Motley Fool Australia.

More reading

• ASX 200 bank shares ‘don’t appear overly expensive’ compared to global peers: UBS
• Which ASX shares to buy if interest rates rise (and which to avoid)
• Can the good times keep rolling for ASX 200 bank shares in FY25?
• 2 ASX 200 bank shares smashing new multi-year highs today
• Is it time to cash in these 2 ASX large-cap stocks?

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

To say that Fortescue Ltd (ASX: FMG) shares had a turbulent ride in FY24 would be an understatement.

The stock whipsawed from lows of $19.40 per share in September last year to highs of $29.88 by the end of January. With a large consolidation in the iron ore price, the mining giant’s shares are now fetching $22.62 apiece.

In other words, shareholders watched their Fortescue stock move a total of $17.74 per share in that time, including both up and down moves.

The mining stock is now valued at a price-to-earnings ratio (P/E) ratio of 7.7 times, with a trailing dividend yield of 9.64%.

Let’s dive into the key highlights from FY24 that you need to know.

Strong first half for Fortescue shares

A strong iron ore price kept Fortescue shares buoyant in the first half of the financial year.

Currently, iron ore is priced at US$113 per tonne. This is after it peaked at US$144 per tonne in January, finishing an 8 %rally starting in August 2023.

This strength inflected positively on Fortescue’s H1 FY24 results. It clipped a 24% rise in the average revenue per dry metric tonne (dmt) of iron ore sold.

This translated to a 21% increase in revenue to US$9.5 billion, while net profit after tax (NPAT) surged by 41%.

That means that for every new $1 in revenues, Fortescue produced $1.95 in NPAT, which is quite the result.

Consequently, free cash flow increased by 68% year over year to US$2.66 billion, while net debt was reduced by almost half.

The company also rewarded shareholders with a 44% increase in the interim dividend, which is now at A$1.08 per share.

As a result, Fortescue shares were a winner in the first half of FY24. They saw a roughly 33% rise in that period.

But the second half, though? Almost a complete reversal.

Challenges arose from Q3

Despite the strong first half, Fortescue faced some hurdles in Q3 FY24. Not least, the pricing of iron ore weakened significantly and hit a low of around US$100 per ton in April.

Unsurprisingly, the company reported an average revenue per dmt of US$104 per tonne, down almost 4% from its first-half results.

Fortescue reported that iron ore shipments for the three months ended 31 March were 43.3 million tonnes (Mt), down 6% from the previous year. It was also below consensus estimates.

Some of the shortfall was attributed to an ore car derailment and some to weather disruptions. Thankfully, a record shipment month in March helped mitigate the impact. The stock consequently finished the financial year roughly in line with where it started.

Future prospects and iron ore prices

Fortescue shares are highly sensitive to iron ore prices. Looking ahead, the iron ore market remains volatile.

UBS forecasts an average iron ore price of US$113 per tonne for the rest of 2024 – flat with today’s price.

But predicting future iron ore prices is challenging, given commodity markets’ cyclical and unpredictable nature.

While Trading Economics forecasts a potential rebound to US$126 per tonne in the next 12 months, much will depend on economic conditions in China, a major consumer of iron ore.

According to my colleague Tristan, the recent economic data from China has shown a decline in house prices and reduced industrial demand, which could impact future prices.

Goldman Sachs sees further risks for Fortescue shares in FY25. In a July note, the broker reiterated its sell rating on Fortescue, stating that its upcoming guidance “will disappoint.”

It said:

We maintain Sell rating on: (1) Relative valuation vs. BHP & RIO, (2) Widening of low grade 58% Fe product realisations over the medium to long term, (3) Execution and ramp-up risks on Iron Bridge and Gabon, (4) Uncertainties around Fortescue Energy diversification (such as the recent approval of the Phoenix hydrogen hub) and Pilbara decarbonisation and impact on dividend and balance sheet.

The stock is also rated a sell by consensus, according to CommSec. No brokers rate it a buy.

Fortescue shares’ FY24 wrap

Fortescue shares were volatile in FY24, but that’s the risk of owning an ASX mining stock. They are price takers on the commodities they sell – not price setters. Fluctuations in the price of iron ore are likely to strongly influence Fortescue shares.

This year to date, Fortescue is down 22%, having slid 7% into the red in the past month.

The post Fortescue shares: Here are the must-know highlights from FY24 appeared first on The Motley Fool Australia.

More reading

• Fortescue shares red-hot as court reveals company espionage
• What is the outlook for ASX 200 dividend shares in FY25?
• Is the Fortescue share price too low to ignore?
• 3 ASX 200 mining shares just downgraded by top brokers
• Are Fortescue shares a contrarian buy after falling 20% in a month?

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

It was a difficult 12 months for Pilbara Minerals Ltd (ASX: PLS) shares in the last financial year.

During the period, the lithium miner’s shares lost 37% of their value.

This means that a $5,000 investment in the company’s shares at the start of FY 2024 would have turned into approximately $3,150.

Whereas the same investment in the Vanguard Australian Shares Index ETF (ASX: VAS) would have become $5,375. And that’s not including the dividends the ETF paid out over the 12 months.

What happened to Pilbara Minerals shares in FY 2024?

Investors were selling ASX lithium stocks in the last financial year after battery materials prices continued to fall.

In 2022, the lithium carbonate price averaged US$63,232 a tonne and the lithium spodumene (6%) price averaged US$4,368 a tonne. These high prices were underpinned by insatiable demand and supply shortages.

Cracks started to form in 2023, which led to these battery making ingredients averaging US$32,694 a tonne and US$3,712 a tonne, respectively.

Since then, prices have been in free fall. So much so, spot prices (in China) were US$11,167 a tonne for lithium carbonate and US$1,060 a tonne for spodumene 6% this month.

And while the company’s operations remain profitable at these levels thanks to their low costs of A$900 per tonne (CIF), the amount of profit Pilbara Minerals is likely to make this year is now nowhere near the levels that the market was forecasting 12 months ago. And hopes of a generous dividend this year have been wiped out.

Making things worse, and putting more pressure on Pilbara Minerals shares, is that analysts believe a lithium surplus will keep prices at these low levels for several years. This could mean a tough few years for the company and its shareholders.

Should you buy the dip?

While analysts at Bell Potter see value emerging, there’s not enough on the table to justify a buy rating at this point. The broker has a hold rating and $3.40 price target on its shares. It commented:

PLS is a large, liquid and clean exposure to global lithium fundamentals and sentiment. PLS is a low-cost producer, it operates in a tier one jurisdiction in Western Australia, and has a strong balance sheet ($1.8b net cash at 31 March 2024) which can withstand weaker lithium prices and support expansion programs. We are confident that EV-led demand will see strong long-term lithium market fundamentals. However, weak near-term lithium market sentiment results in us retaining our Hold recommendation.

The post If I’d invested $5,000 in Pilbara Minerals in FY24 what would I have now? appeared first on The Motley Fool Australia.

More reading

• ASX lithium shares: Screaming bargains or falling knives?
• Down 42%: Are Pilbara Minerals shares good value now?
• Which ASX lithium shares are financially primed to survive this rut?
• Top broker says Pilbara Minerals shares are ‘a super buy at these levels’
• Is it time to buy FY24’s worst-performing ASX shares?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

In the 2024 financial year that has just passed us by, ASX shares had an uncommonly good time. The shares of Washington H. Soul Pattinson and Co Ltd (ASX: SOL), or Soul Patts for short? Not so much.

Between 1 July 2023 and 30 June 2024, the S&P/ASX 200 Index (ASX: XJO) rose by a healthy 7.3%. Factoring in dividend returns, anyone who owned an ASX 200 index fund would have banked roughly 12% last financial year. Not bad for an index that typically returns 7-8% per annum.

But Soul Patts shares couldn’t quite match that performance. This ASX 200 investing house started July 2023 going for $31.78 each. Last week, those same shares wrapped up FY24 at a price of $32.82.

Sure, that 3.27% gain over FY24 is better than a poke in the eye with a blunt stick. But it falls far short of being a market-matching (let alone beating) investment – a typical criterion we use for assessing the quality of ASX shares as investments.

Soul Patts’ dividends do narrow that gap a little. The company forked out 91 cents per share in fully-franked dividends last financial year. At the company’s starting FY24 price, that adds a yield worth another 2.86% to Soul Patts’ FY24 total return.

Even so, we can conclude that FY24 was a lacklustre one for Soul Patts shares and their owners.

As an owner myself, this doesn’t bother me though. In fact, I think it’s a great opportunity to pick up some more.

Buying Soul Patts shares when they’re ‘marked down’

Why? Well, the legendary Warren Buffett once said, “Whether we’re talking about socks or stocks, I like buying quality merchandise when it is marked down”.

Soul Patts is a company that usually delivers market-beating returns, not market-trailing ones. Back in May, the company affirmed that its shares had averaged a total return of 12% per annum (share price growth plus dividends) over the 20 years to 30 April 2024. That beat the ASX market by 3.3% per annum on average.

But not this year. So, by definition, that makes Soul Patts’ stock ‘marked down’, as Buffett would say.

Say Soul Patts blew the lights out with a 20% rise in FY24. If that were the case, I wouldn’t be in a rush to buy more shares today. However, as the company had a lacklustre year, it is now high on my buy list for FY25.

If the company sticks to its historical average and delivers a 12% return over the coming 12 months (which I think is very possible, but not guaranteed), I’ll be glad to have bought shares.

The post Soul Patts shares had a lacklustre FY24. Here’s why I can’t wait to buy more appeared first on The Motley Fool Australia.

More reading

• ASX passive income: How to make $1,000 per month
• Beginner investors: I suggest you start with these 2 ASX dividend powerhouses for decades of income
• These 3 ASX shares have unstoppable dividend growth
• 1 ASX stock that’s just right for beginner investors
• If I were 60 I’d buy these ASX shares for dividends

Motley Fool contributor Sebastian Bowen has positions in Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has positions in and has recommended Washington H. Soul Pattinson and Company Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Every month, analysts at Morgans pick out their best ASX stock ideas.

These are the ASX stocks that the broker thinks offer the highest risk-adjusted returns over a 12-month timeframe. Morgans notes that they are supported by a higher-than-average level of confidence.

Among its best ideas for July are the three ASX stocks listed below. Here’s what the broker is saying about them:

Clearview Wealth Ltd (ASX: CVW)

Morgans thinks that Clearview Wealth could be an ASX stock to buy. It is an Australian financial services company offering life insurance, superannuation and investment products and services.

The broker is feeling very positive about the company’s outlook. Particularly given its business transformation program, which it expects to support strong earnings. In addition, it highlights Clearview’s solid balance sheet and undemanding valuation. It said:

CVW is a challenger brand in the Australian retail life insurance market (market size = ~A$10bn of in-force premiums). CVW sees its key points of differentiation as its: 1) reliable/trusted brand; 2) operational excellence (in product development, underwriting and claims management); and 3) diversified distributing network. CVW’s significant multiyear Business Transformation Program has, in our view, shown clear signs of driving improved growth and profitability in recent years. We expect further benefits to flow from this program in the near term, and we see CVW’s FY26 key business targets as achievable. With a robust balance sheet, and with our expectations for ~21% EPS CAGR over the next three years, we see CVW’s current ~11x FY25F PE multiple as undemanding.

Morgans has an add rating and 78 cents price target on it shares.

Elders Ltd (ASX: ELD)

Another ASX stock that Morgans is bullish on in July is Elders. It is a leading agribusiness company.

Morgans believes that FY 2025 could be the start of a good run of earnings growth for Elders and sees now as the time to buy. It said:

ELD is one of Australia’s leading agribusinesses. It has an iconic brand, 185 years of history and a national distribution network throughout Australia. With the outlook for FY25 looking more positive and many growth projects in place to drive strong earnings growth over the next few years, ELD is a key pick for us. It is also trading on undemanding multiples and offers an attractive dividend yield.

The broker has an add rating and $9.00 price target on its shares.

TechnologyOne Ltd (ASX: TNE)

A third ASX stock that Morgans thinks could be a buy is enterprise software provider TechnologyOne.

Its likes the company due partly to its large cash balance and impressive track record of earnings growth. In addition, it suspects that the latter could be about to accelerate. Its analysts said:

TNE is an Enterprise Resource Planning (aka Accounting) company. It’s one of the highest quality companies on the ASX with an impressive ROE, nearly $200m of net cash and a 30-year history of growing its earnings by ~15% and its dividend ~10% per annum. As a result of its impeccable track record TNE trades on high PE. With earnings growth looking likely to accelerate towards 20% pa, we think TNE’s trading multiple is likely to expand from here.

Morgans has an add rating and $20.50 price target on its shares.

The post Morgans names the best ASX stocks to buy in July appeared first on The Motley Fool Australia.

More reading

• Can ASX 200 tech shares produce another strong performance in FY25?
• Leading brokers name 3 ASX shares to buy today
• 5 things to watch on the ASX 200 on Monday
• 3 fantastic ASX growth shares to buy in July
• Here’s how the ASX 200 market sectors stacked up last week

Motley Fool contributor James Mickleboro has positions in Technology One. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One. The Motley Fool Australia has recommended Elders and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Income investors certainly are a lucky bunch. The Australian share market is filled to the brim with dividend-paying shares.

But which ones could be buys right now for income investors? Let’s take a quick look at three ASX dividend shares that have been given the thumbs up by analysts. They are as follows:

BHP Group Ltd (ASX: BHP)

The Big Australian could be a top option for income investors this month according to analysts at Morgans.

Its analysts highlight that the mining giant’s “basket of market exposures share the similar characteristic of typically boasting bumper margins throughout the cycle.” This means that BHP consistently generates large amounts of free cash flow, which is supportive of big dividend payments.

Morgans expects this trend to continue in the near term and is forecasting fully franked dividends of approximately ~$2.42 per share in FY 2024 and then ~$2.17 per share in FY 2025. Based on the current BHP share price of $44.77, this equates to dividend yields of 5.4% and 4.85%, respectively.

The broker has an add rating and $48.30 price target on the miner’s shares.

Inghams Group Ltd (ASX: ING)

Morgans is also tipping Inghams as an ASX dividend share to buy this month. It is Australia’s leading poultry producer and supplier.

The broker has described Ingham’s shares as “undervalued” at current levels. Particularly given its market leadership and favourable consumer trends.

Its analysts expect this to underpin some generous dividend yields in the near term. They are forecasting fully franked dividends of 22 cents per share in FY 2024 and then 23 cents per share in FY 2025. Based on the current Inghams share price of $3.72, this equates to dividend yields of 5.9% and 6.2%, respectively.

Morgans has an add rating and $4.40 price target on its shares.

Orora Ltd (ASX: ORA)

Over at Goldman Sachs, its analysts think income investors should buy Orora shares.

They believe the packaging company’s shares could be cheap after crashing deep into the red over the past 12 months.

In addition, Goldman expects some good yields from its shares. It is forecasting dividends per share of 12 cents in FY 2024 and 13 cents in FY 2025. Based on the current Orora share price of $1.98, this will mean yields of 6.1% and 6.55%, respectively.

The broker also sees major upside potential for its shares. It has a buy rating and $3.00 price target on them.

The post Buy BHP and these ASX dividend shares appeared first on The Motley Fool Australia.

More reading

• Morgans names 3 ASX 200 stocks to buy in July
• Top brokers name 3 ASX shares to buy today
• I’d buy BHP shares to generate $1,000 of monthly passive income
• 5 things to watch on the ASX 200 on Wednesday
• Here are the top 10 ASX 200 shares today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has recommended Orora. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX lithium shares counted among the worst stock market performers in the year just past.

Taking a look at the share prices over the past 12 months, the All Ordinaries Index (ASX: XAO) has gained a respectable 8%. And that’s not including the dividends a number of those stocks pay out.

As for ASX lithium shares, here’s how some of the top names performed over this same period:

• Pilbara Minerals Ltd (ASX: PLS) shares are down 41%
• Core Lithium Ltd (ASX: CXO) shares are down 91%
• IGO Ltd (ASX: IGO) shares are down 62%
• Liontown Resources Ltd (ASX: LTR) shares are down 67%
• Sayona Mining Ltd (ASX: SYA) shares are down 83%
• Lake Resources (ASX: LKE) shares are down 87%

I think we can all agree these are some fast falling knives.

What’s happening with lithium prices?

As you’re likely aware, lithium producers and explorers across the globe have come under heavy selling pressure as the price of the battery critical metal crashed from all-time highs of more than US$8,000 per tonne in November 2022 to just under US$1,000 a tonne this week.

The massive retrace that’s been pressuring ASX lithium shares came as rapid global supply growth outpaced slower than expected demand growth.

On the demand side, EV growth rates in the EU and US have dropped markedly as electric vehicles struggle to compete with cheaper combustion powered rivals.

What’s next for ASX lithium shares?

Whether ASX lithium shares represent screaming bargains after the past year’s dismal performance or remain falling knives hinges on what we can expect for lithium prices.

And on that front, the medium-term outlook looks grim, with most analysts forecasting subdued prices for several years to come.

According to UBS analyst Levi Spry (quoted by The Australian Financial Review), “With a view that lithium markets remain well to over-supplied, we expect prices to stay lower for longer.”

UBS rates lithium producers a sell “where valuations still appear stretched”. The broker estimates that markets are still pricing lithium in the range of US$1,200 to US$1,480 per tonne.

Commenting on what drove the boom in ASX lithium shares, NabTrade’s head of investor behaviour Gemma Dale said (quoted by ABC News):

Seeing Tesla Motors (NASDAQ: TSLA) go to the Moon, there was just a lot of heat in that sector. And what it meant was that investors were chasing a lot of companies that were not hyper viable. There was a lot of hype.

Falling knives or screaming bargains?

Over the short to medium-term, then, ASX lithium shares look more like falling knives that could pare down your initial investment.

However, long-term investors may well look back at today’s beaten-down prices as screaming bargains.

“Those [lithium stocks] who have sort of strong, viable business models will perform in the long run. The ones that were a little bit more speculative might not play out quite so well,” Dale said.

Earlier this week, Richard Coppleson, director of institutional sales and trading at Bell Potter, labelled ASX lithium share Pilbara Minerals “a super buy at these levels”.

Coppleson said, “When lithium does recover, this is back to $5; only question is when will that be?”

Pilbara Minerals shares are currently trading for $3.05 apiece.

Now, whether you’re looking to buy ASX lithium shares or any other stocks, be sure to do your own research first. If you’re not comfortable with that or don’t have the time, just reach out for some expert advice.

The post ASX lithium shares: Screaming bargains or falling knives? appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• 2 EV trends Tesla and Rivian investors should understand now
• Why Tesla shares kept rallying today
• Down 42%: Are Pilbara Minerals shares good value now?
• Why the Liontown share price could jump 25%+

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Tesla. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Are you on the lookout for some big dividend yields? If you are, then it could be worth checking out the three ASX dividend stocks in this article.

That’s because they have been named as buys and tipped to offer yields of greater 7%+ in the near term. Here’s what analysts are forecasting from them:

Accent Group Ltd (ASX: AX1)

Accent Group could be a great ASX dividend stock to buy according to analysts at Bell Potter. It is a leading leisure footwear retailer with a large network of stores across multiple brands. This includes HypeDC, Platypus, and The Athlete’s Foot.

Bell Potter likes the company. It notes that it remains “constructive on AX1 given the scale & exposure in terms of channels, brands & size as the overall industry navigates a challenging retail spend environment.”

The broker expects this to allow the company to pay fully franked dividends per share of 13 cents in FY 2024 and then 14.6 cents in FY 2025. Based on the latest Accent share price of $1.88, this represents dividend yields of 6.9% and 7.8%, respectively.

Bell Potter currently has a buy rating and $2.50 price target on its shares.

APA Group (ASX: APA)

Another high-yield ASX dividend stock for investors to consider buying is APA Group. It is an energy infrastructure company that owns, manages, and operates a portfolio of gas, electricity, solar and wind assets.

Macquarie is positive on the company and expects its long run of dividend increases to continue. It is forecasting dividends per share of 56 cents in FY 2024 and then 57.5 cents in FY 2025. Based on the current APA Group share price of $7.88, this equates to 7.1% and 7.3% dividend yields, respectively.

Its analysts currently have an outperform rating and $9.40 price target on its shares.

Dexus Convenience Retail REIT (ASX: DXC)

A third ASX dividend stock that could be a great option for income investors is Dexus Convenience Retail REIT. It owns a portfolio of service station and convenience retail assets across Australia.

Morgans believes the company is positioned to reward shareholders with some big dividends in the near term. It is forecasting dividends per share of 21 cents in both FY 2024 and FY 2025. Based on its current share price of $2.62, this implies dividend yields of 8% for both years.

The broker currently has an add rating and $3.23 price target on its shares.

The post Analysts say these ASX dividend stocks with ~7% yields are top buys appeared first on The Motley Fool Australia.

More reading

• Australian dividend machines: 3 ASX shares that generate reliable passive income
• ASX 200 stock slips on $145 million impairment
• Why APA Group, Chalice Mining, Guzman Y Gomez, and Monadelphous shares are falling
• 3 cheap ASX passive income shares I’d buy to target $1,000 a month
• Which ASX dividend shares are predicted to have the highest yields in FY25?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Apa Group and Macquarie Group. The Motley Fool Australia has recommended Accent Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

When reviewing some of the best performers of the ASX All Ords in FY24, it can seem deceptively easy to make major money on the share market, can’t it?

While past performance is never a guarantee of future performance, let’s take a look at some of the ASX All Ords shares that went gangbusters in FY24, delivering some mesmerising share price gains.

5 ASX All Ords shares that skyrocketed in FY24

Clarity Pharmaceuticals Ltd (ASX: CU6)

ASX All Ords healthcare share Clarity Pharmaceuticals screamed 674.29% higher in FY24. Excitement is building around Clarity’s highly targeted radiopharmaceuticals that can be used for both the diagnosis and treatment of serious diseases, including cancer.

The bulk of the stock’s meteoric price rise in FY24 began in April. The company announced that the first patient ever to be dosed with two cycles of 67Cu-SAR-bisPSMA at 8GBq achieved a complete response to treatment based on RECIST criteria. That meant the patient had maintained undetectable levels of prostate cancer for almost six months.

Droneshield (ASX: DRO)

The share price of ASX All Ords defence company Droneshield went skyward in FY24, rising 647.83%.

The stock got a substantial lift in January after the company launched its Expeditionary Fixed-Site (EFS) Kit for the DroneSentry-X Mk2, which provides AI-driven detection, identification and defeat capabilities for mobile and expeditionary uses.

Another game-changing announcement came in May when Droneshield revealed a repeat order of A$5.7 million from a US Government customer for several of its CUxS (Counter-UxS) systems.

Spartan Resources Ltd (ASX: SPR)

ASX All Ords gold miner Spartan Resources (formerly known as Gascoyne Resources) had a fantastic year in FY24, with the share price rising 482.35%. Spartan owns the Dalgaranga Gold Project, located 65km northwest of Mt Magnet in Western Australia’s Murchison Region.

The stock moved up steadily all year but got a good bump in March when the company released assay results showing the Never Never Gold Deposit was 1km deep. In May, further drilling results also excited the market and put the stock on a steeper upward trajectory through to the end of FY24.

Nuix Ltd (ASX: NXL)

ASX All Ords technology stock Nuix edged higher all year, racking up a 262.35% share price gain for FY24.

The analytics and intelligence software provider released a bullish FY24 earnings update in May. Nuix was forecasting that its FY24 statutory earnings before interest, taxes, depreciation, and amortisation (EBITDA) would increase by more than 35% to be in the range of $47 million to $52 million. Just two weeks later, the company updated those forecasts again and is now expecting EBITDA of $55 million to $60 million.

Zip Co Ltd (ASX: ZIP)

Shares in this ASX All Ords buy now, pay later (BNPL) company zipped 256.1% higher over the course of FY24.

The stock began a gradual lift in value from October, brought about by strong first-quarter results. The Zip share price got another boost on the back of the half-year update released in January.

But it wasn’t all smooth sailing. The BNPL stock gave back 10.5% of its gains on 16 April, the day it released its third-quarter results. The Zip share price then recovered to finish the year a few cents shy of its 52-week high.

The post 5 ASX All Ords shares that rose 250% to 700% in FY24 appeared first on The Motley Fool Australia.

More reading

• Zip shares surge 10%, bringing gains to 55% in a month
• DroneShield share price roars to yet another all-time high in 2024 surge
• The three best ASX All Ords shares to buy and hold in FY 2024 unveiled
• Move over DroneShield: This ASX defence stock is up 67% in a month!
• 2 All Ords ASX defence shares ‘poised to thrive’

Motley Fool contributor Bronwyn Allen has positions in Zip Co. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield and Zip Co. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.